Related Experiment Video

Updated: Mar 28, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.7K

Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and

Benjamin Y Lu1, Shivani U Thanawala2, Kelly C Zochowski2

  • 1a Perlmutter Cancer Center , New York University Langone Medical Center , New York , NY , USA ; Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA ;

Leukemia & Lymphoma
|January 5, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.2K

Related Experiment Videos

Last Updated: Mar 28, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.7K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.2K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

Articles linked to this work by shared authors, journal, and citation graph.

Phenotypic and functional characterization of tumor-reactive T cells in malignant pleural effusions.

Cancer immunology research·2026

Medical Management of Non-Small Cell Lung Cancer Brain Metastases in the Modern Era.

Cancer journal (Sudbury, Mass.)·2026

The transcription factor Eomes drives a stemness program in CD4+ T cells that promotes anti-tumor immunity in response to immunotherapy.

Immunity·2026

NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects.

Molecular cancer·2026

Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group.

Blood advances·2026

Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes.

Blood advances·2026

Diagnostic accuracy and clinical usefulness of lung ultrasound in onco hematological patients with neutropenic fever.

Leukemia & lymphoma·2026

Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

Leukemia & lymphoma·2026

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Leukemia & lymphoma·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Leukemia & lymphoma·2026

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Leukemia & lymphoma·2026

A scalable outpatient framework for BI-RADS 2-4B breast nodule management: an iodine-DMSO transdermal protocol.

Frontiers in health services·2026

Spontaneous rupture of the urinary bladder and hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a case report.

Journal of surgical case reports·2026

Case Report: Life-threatening neutropenia with absolute neutrophil count of zero after low-dose regional arterial infusion chemotherapy to lung in a patient with advanced triple-negative breast cancer after multiple lines of treatment.

Frontiers in oncology·2026

Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to Venetoclax.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

A Giant in the Neck: Cytomorphology of a Rare Cervical Vertebral Lesion.

Cytopathology : official journal of the British Society for Clinical Cytology·2026

Multiparametric MRI differentiation of ovarian endometriomas and hemorrhagic cysts: Quantitative shading, ADC measurements, and morphological sign analysis.

Acta radiologica (Stockholm, Sweden : 1987)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us